MedPath

StableEyes With Active Neurofeedback

Not Applicable
Recruiting
Conditions
Motion Sickness
Vestibular Disorder
Vestibular Schwannoma
Space Motion Sickness
Interventions
Device: SWAN
Behavioral: Traditional Therapy
Registration Number
NCT05622344
Lead Sponsor
Johns Hopkins University
Brief Summary

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Detailed Description

The rehabilitation device guides users to perform sinusoidal head rotations, matched to a metronome, about the yaw, pitch, and roll axes (60 sec epochs, 5 minutes per axis, 15 min total). The assessment for each axis consists of the number of completed epochs with each epoch requiring head rotations of a different amplitude. Subjects are instructed to begin with an 'easy' amplitude (i.e. small) and increase or decrease amplitude depending on the subject's perception of motion sickness - which is input from 0 (absent motion sick) to 11 (vomit) using a handheld controller. Video-oculography captures eye and head velocity as well as tracks the number of blinks and saccades, metrics that can indicate worsening nausea.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
48
Inclusion Criteria
  1. Provision of signed and dated informed consent form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
  4. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen
Exclusion Criteria
  1. Current use of anti-nausea medication
  2. Presence of cervical spine pathology that limits head motion to < 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
  3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
  4. Legal blindness (20/200 or worse visual acuity)
  5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SWAN Motion Sick DaytonSWANHealthy control subjects that meet similar similar physical characteristics of astronauts will receive the automated vestibular rehabilitation method post motion sickness.
Traditional VPT JHUTraditional TherapySubjects that have had their eighth cranial nerve resected will receive traditional vestibular rehabilitation exercises at Johns Hopkins University (JHU) site.
SWAN VPT JHUSWANSubjects that have had their eighth cranial nerve resected will receive the automated vestibular rehabilitation method
Primary Outcome Measures
NameTimeMethod
Change in Motion sickness intensity as assessed by subjective ratingDaily for up to 4 weeks

Subjective rating of motion sickness intensity from 0 to 10. Zero denotes absent motion sickness while 10 denote vomiting.

Secondary Outcome Measures
NameTimeMethod
Change in Rod and Frame TestDaily for up to 4 weeks

Subjects adjust a virtual line to their perceived vertical, measured in degrees.

Change in Timed Up and Go PlusDaily for up to 4 weeks

Time measured in seconds for a subject to stand up, step over an obstacle then walk 3M before turning around and sitting down.

Change in Foam Stance - Eyes Open with head motionDaily for up to 4 weeks

Time to seconds to stand on foam with eyes open while moving head up and down. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling.

Change in Foam Stance - Eyes Closed with head motionDaily for up to 4 weeks

Time in seconds to stand on foam with eyes closed while moving head up and down. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling.

Change in Vestibulo-Ocular Reflex (VOR) gain as measured by video-oculographyDaily for up to 4 weeks

Ratio of eye velocity to head velocity that varies from 0 to 1.2. Normal scores are greater than 0.8.

Change in Foam Stance - Eyes ClosedDaily for up to 4 weeks

Time in seconds to stand on foam with eyes closed. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling.

Change in Number of blinks as measured by video-oculographyDaily for up to 4 weeks

Increase blinking is correlated with worse motion sickness.

Change in Heart rate as measured by a monitor worn over the forearmDaily for up to 4 weeks

Heart rate in beats per minute will be measured using a monitor worn over the forearm.

Change in Foam Stance - Eyes OpenDaily for up to 4 weeks

Time in seconds to stand on foam with eyes open. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling.

Change in Gait speedDaily for up to 4 weeks

Velocity to walk 6m within a 10m marked distance, measured in meters/second. Normative data exists based on decade of age.

Change in Gait enduranceDaily for up to 4 weeks

Distance walked in 2 minutes, measure in meters.

Change in Rod and Disk TestDaily for up to 4 weeks

Subjects adjust a virtual line to their perceived vertical, measured in degrees.

Change in Vertical and torsional alignment nulling test (VAN and TAN)Daily for up to 4 weeks

Vertical alignment nulling and torsional alignment nulling ask subjects to adjust lines to there perceived horizontal. Measured in degrees.

Change in Daily Activity as assessed by an activity monitorDaily for up to 4 weeks

Subjects wear an activity monitor on their wrist Data includes daily distance walked .

Change in Subjective Visual VerticalDaily for up to 4 weeks

Subjects adjust a virtual line to their perceived vertical, measured in degrees.

Trial Locations

Locations (2)

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

Naval Medical Research Unit

🇺🇸

Dayton, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath